Shanghai Pioneer Holding Ltd. logo

Shanghai Pioneer Holding Ltd. (1345)

Market Closed
12 Aug, 08:00
HKEX HKEX
2. 27
HKD
0
0%
HKD
2.41B Market Cap
- P/E Ratio
0.13% Div Yield
30,000 Volume
- Eps
2.27 HKD
Previous Close
Add Transaction
Day Range
2.27 2.27
Year Range
1.59 2.4
Want to track 1345 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

1345 closed yesterday higher at 2.27 HKD, an increase of 0% from Tuesday's close, completing a monthly decrease of -2.1552% or -0.05 HKD. Over the past 12 months, 1345 stock lost -0.4386%.
1345 pays dividends to its shareholders, with the most recent payment made on Jun 18, 2026. The next estimated payment will be in In 4 months on Dec 18, 2026 for a total of 0.054 HKD.
The stock of the company had never split.
The company's stock is traded on one exchange.

1345 Chart

People also search for

Luye Pharma Group Ltd.
2.12 HKD
+0.4751%
Carsgen Therapeutics Holdings Limited
15.45 HKD
-2.3388%
Beijing Biostar Pharmaceuticals, Co., Ltd.
3.38 HKD
-3.4286%
Aim Vaccine Co. Ltd.
1.53 HKD
+0.3279%
CK Life Sciences Int'l.,
0.54 HKD
-2.7027%

Shanghai Pioneer Holding Ltd. (1345) FAQ

What is the stock price today?

The current price is 2.27 HKD.

On which exchange is it traded?

Shanghai Pioneer Holding Ltd. is listed on HKEX.

What is its stock symbol?

The ticker symbol is 1345.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.13%.

What is its market cap?

As of today, the market cap is 2.41B.

Has Shanghai Pioneer Holding Ltd. ever had a stock split?

No, there has never been a stock split.

Shanghai Pioneer Holding Ltd. Profile

Pharmaceuticals Industry
Healthcare Sector
Mr. Yuewen Yang CEO
HKEX Exchange
G2162L106 CUSIP
China Country
343 Employees
3 Jun 2026 Last Dividend
- Last Split
- IPO Date

Overview

Shanghai Pioneer Holding Ltd operates as an influential investment holding entity, focusing its efforts on the marketing, promotion, and sale of a wide array of pharmaceutical products and medical devices within the People's Republic of China's market. Originally known under the name China Pioneer Pharma Holdings Limited, the company rebranded to better reflect its evolving role and broader ambitions in the healthcare sector. Since its inception in 1996, Shanghai Pioneer Holding Ltd has committed to addressing the diverse healthcare needs by offering a comprehensive portfolio that spans various therapeutic areas including ophthalmology, pain management, cardiovascular, immunology, gynecology, gastroenterology, among others. Moreover, the company's dedication to innovation and quality extends into the realm of medical devices, covering specialties such as ophthalmology, orthopedics, odontology, and wound care. Strategically headquartered in Shanghai, this subsidiary of Pioneer Pharma (BVI) Co., Ltd., capitalizes on its extensive network, distributing its products mainly to hospitals, medical institutions, and pharmacies. Additionally, the company diversifies its operations through the sale of ancillary tools, dental devices, imported in-licensed prescription products, and engaging in the research and development of denture and implant dentistry, complemented by metal finishing services. This holistic approach enables Shanghai Pioneer Holding Ltd to play a pivotal role in enhancing healthcare outcomes across China.

Products and Services

  • Pharmaceutical Products:

    Offers a broad spectrum of pharmaceutical products targeting various therapeutic areas such as ophthalmology, pain management, cardiovascular, immunology, gynecology, and gastroenterology. Each product adheres to stringent quality standards to ensure effective patient care.

  • Medical Devices:

    The company's medical device portfolio includes innovations in ophthalmology, orthopedics, odontology, and wound care, designed to meet the diverse needs of healthcare professionals and patients. These devices embody the company's commitment to delivering state-of-the-art healthcare solutions.

  • Ancillary Tools and Dental Devices:

    Expands its offerings beyond traditional medical devices to include ancillary tools and dental devices, catering to specific needs within the healthcare industry such as denture and implants dentistry. This range reflects the company's dedication to comprehensive healthcare.

  • In-licensed Prescription Products:

    Engages in the sale of imported in-licensed prescription products, which supplement its core offerings and ensure a wider range of therapeutic solutions are accessible to the Chinese market. These products are carefully selected to align with the company’s quality and efficacy standards.

  • Research and Development:

    Devotes resources to research and development with a focus on denture and implants dentistry, aiming to push the boundaries of what is possible in dental care and orthopedics. This initiative demonstrates Shanghai Pioneer Holding Ltd’s commitment to innovation and advancement in the healthcare sector.

  • Metal Finishing Services:

    Offers specialized metal finishing services, an essential component in the manufacturing processes of many medical devices. This service underscores the company’s capability to provide comprehensive solutions across the value chain of medical device production.

Contact Information

Address: No.15, Lane 88 Wuwei Road
Phone: 86 21 5049 8986